AI assists in arthritis diagnosis based on MRI images 

A fully automated machine learning algorithm predicts bone marrow inflammation in MRI scans

Ghent, 28 August 2023 – A fully automated machine learning algorithm can now predict bone marrow inflammation, known as bone marrow edema, in MRI scans. This innovative algorithm, developed by the teams of Prof. Yvan Saeys and Prof. Dirk Elewaut at the VIB-UGent Center for Inflammation Research and colleagues at University Hospital Ghent (UZGent), offers an objective and standardized way to evaluate inflammatory lesions, and it has the potential to impact the diagnosis and treatment of spondyloarthritis patients significantly. The work appears in Arthritis & Rheumatology 

Detecting inflammation 

Traditionally, the detection of active sacroiliitis (inflammation of the sacroiliac joint that connects our hips to our spine) plays a crucial role in the early diagnosis and monitoring of inflammatory conditions such as spondyloarthritis. However, evaluating MRI scans of this joint is challenging due to the variability of inflammatory lesions and the expertise required for accurate interpretation. 

While most of the news is concerned about chatbots, AI is revolutionizing medical imaging. In this new study, researchers from VIB-UGent and UZGent developed a computer vision workflow to automate the entire process from detecting the SI joint and segmenting the regions to predicting bone marrow edema. ​ 

Dr. Joris Roels (VIB-UGent): "Our algorithm was trained and tested using a diverse dataset of arthritis patients, postpartum individuals, and healthy subjects. The predictions were further validated using an independent dataset of MRI scans from arthritis patients." 
"With that training," Dr. Ann-Sophie De Craemer (UZGent) adds, "we got promising results from our machine learning model, with roughly between 70 and 80% accuracy in detecting inflammation in the sacroiliac joint." ​ 

Assisting diagnosis 

Getting automated predictions of inflammation from three-dimensional images of a complex anatomical structure is very challenging, but by ‘segmenting’ the image into more detailed sections, this new algorithm can make the search space smaller, which leads to better predictions. ​ 

Prof. Dirk Elewaut (VIB-UGent): "We developed a fully automated machine learning pipeline that allows a standardized evaluation of sacroiliac inflammation on MRI scans. This method can potentially screen large numbers of suspected arthritis patients and brings us one step closer to using artificial intelligence for diagnosis and follow-up." 
Prof. Yvan Saeys (VIB-UGent) adds: "With further refinement and validation, this technology could revolutionize healthcare practices and improve patient outcomes. The role of AI here is not to replace, but to assist human specialists, so that they gain time for interacting with their patients. ​ Using the explainable AI features of our model, medical experts can now also get a grasp of where the AI model is looking at in the image, rendering our AI models more trustworthy and explainable." 

Publication 

A machine learning pipeline for predicting bone marrow oedema along the sacroiliac joints on magnetic resonance imaging. Roels, De Craemer, et al. Arthritis & Rheumatology. 2023. 


Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

 

 

 

 

 

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be